Bioreactor Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Bioreactor Market is segmented by Type, Usage, Scale, Control (Manual and Automated), and Geography.

Market Snapshot

bioreactor market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.43 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The growth of bioreactors in pharmaceutical, technological advancements in bioreactors, and adoption of single-use bioreactors (SUBs) and hybrid bioreactors are the prime factors responsible for the growth of the bioreactor market currently.

  • Biopharmaceuticals are utilized in a range of applications, from being in the production of biopharmaceuticals to applications in tissue engineering, such as cell expansion and generation of 3D tissue constructs. Bioreactors are, thus, used in providing a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress for any cells or cellular constructs incorporated into them. Bioreactors have been utilized in many different areas of industry and research and for the progression of in vitro models of 2D cultures and suspensions to 3D constructs, mimicking the natural physiological state in situ. They have also proven to be crucial medicines that are used in autoimmune disorders, cancer, asthma, and organ rejection. Thus, the growth of bioreactors in the pharmaceutical sector is the major factor augmenting the growth of the market.
  • Furthermore, the technological advancements in bioreactors have improved the flexibility, quality, and scalability of operations with low capital and energy requirements. The innovative methods and the analytical tools are projected to enhance the process robustness, accelerate scale-up to industrial production, and drive the efficient use of resources. The extensive use of hybrid bioreactor technology in effective waste management has also further accelerated the expansion of the market.

Scope of the Report

As per the scope of the report, bioreactors are large vessels used in industries that provide optimum conditions for the growth of microorganisms, to carry out the biochemical process. They are used to speed up the biochemical processes, such as fermentation and antibiotic drug production, where bacteria or yeast are added as inoculum to carry out the reaction.

By Type
Glass
Stainless Steel
Single-use
By Usage
Lab-scale Production
Pilot-scale Production
Full-scale Production
By Scale
5L-20L
20L-200L
200L-1500L
Above 1500L
By Control Type
Manual
Automated (MFCs)
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Single-use Bioreactors Segment is Expected to Grow Fastest During the Forecast Period

Stainless-steel bioreactors from the material type segmentation are expected to hold the largest market share in the coming future. However, the single-use bioreactors are believed to have a faster growth compared to that of glass material bioreactors and stainless-steel bioreactors. Single-use bioreactors are expected to witness a CAGR of 7.26% over the forecast period.

In recent years, the single-use bioreactors have been increasingly adopted in the modern biopharmaceutical processes. This is primarily due to their unique ability to enhance flexibility, reduce investment, and limit operational costs. The recent years have observed companies specializing in the development of single-use bioreactors, using a process that can modify the existing glass bioreactors to a single-use bioreactor in seconds. Distek Inc. also developed a benchtop SUB system for mammalian cell growth and recombinant protein production. The increasing funding for the biotechnology segment is also boosting the segment’s growth. Therefore, owing to the above reasons, this segment is expected to have the fastest growth in the near future.

Biotech

North America holds the Largest Market Share currently and is Expected to Continue Over the Forecast Period

North America currently dominates the market for bioreactors, and it is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future owing to the rise in collaborations among the industry and academic institutions. The United States holds the majority of the market in the North American region; this is because pharmaceuticals and hi-tech product makers have announced multimillion-dollar investments to expand manufacturing capabilities.

The growing demand for biopharmaceutical products in the region and the focus to increase localized production are expected to have a positive impact on the market over the forecast period.

Bioreactor Market - Growth Rate by Region

Competitive Landscape

The bioreactor market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products at lower prices. Companies, like Sartorius AG, Thermo Fisher Scientific Inc., Pall Corporation (Danaher Corporation), and Eppendorf AG, hold a significant market share in the bioreactor market.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growth of Bioreactors in Pharmaceuticals

      2. 4.2.2 Technological Advancements in Bioreactors

      3. 4.2.3 Adoption of Single-use bioreactors (SUBs) and Hybrid Bioreactors

    3. 4.3 Market Restraints

      1. 4.3.1 Concerns Regarding the Use of Single-use Bioreactors (SUBs)

      2. 4.3.2 Limited Storage Capacity

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Glass

      2. 5.1.2 Stainless Steel

      3. 5.1.3 Single-use

    2. 5.2 By Usage

      1. 5.2.1 Lab-scale Production

      2. 5.2.2 Pilot-scale Production

      3. 5.2.3 Full-scale Production

    3. 5.3 By Scale

      1. 5.3.1 5L-20L

      2. 5.3.2 20L-200L

      3. 5.3.3 200L-1500L

      4. 5.3.4 Above 1500L

    4. 5.4 By Control Type

      1. 5.4.1 Manual

      2. 5.4.2 Automated (MFCs)

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle-East and Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle-East and Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 GE Healthcare

      2. 6.1.2 Merck KGaA

      3. 6.1.3 Eppendorf AG

      4. 6.1.4 Sartorius AG

      5. 6.1.5 Pall Corporation (Danaher Corporation)

      6. 6.1.6 Applikon Biotechnology Inc.

      7. 6.1.7 Bioengineering AG

      8. 6.1.8 Infors HT

      9. 6.1.9 Pierre Guerin Technologies

      10. 6.1.10 Solaris Biotech

      11. 6.1.11 Thermo Fisher Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Bioreactor Market market is studied from 2018 - 2026.

The Bioreactor Market is growing at a CAGR of 6.43% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

GE Healthcare, Merck KGaA, Eppendorf AG, Sartorius AG, Thermo Fisher Scientific Inc. are the major companies operating in Bioreactor Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!